SIRT1 and cholangiocarcinoma: For example, a key role for SIRT1 as a tumor promoter that inhibits PC formation in CCA cells and induces cell proliferation has been demonstrated by the same group, who also provided a rationale for clinically exploring the use of SIRT1 inhibitors in CCA [128].